Core Viewpoint - Nasdaq is set to launch "around-the-clock trading" services starting in 2026 to meet the growing demand from investors for continuous trading in the U.S. stock market [3][4]. Group 1: Around-the-Clock Trading - Nasdaq plans to extend daily trading hours from 16 hours to 23 hours, operating five days a week, with a new schedule that includes a daytime session from 4:00 AM to 8:00 PM and a night session from 9:00 PM to 4:00 AM [5]. - The initiative aims to enhance the ability of investors, particularly those outside the U.S., to respond quickly to market dynamics occurring outside regular trading hours [6]. - Other exchanges, including the New York Stock Exchange and the Chicago Board Options Exchange, have announced similar plans for around-the-clock trading [4]. Group 2: Medline IPO - Medline, the largest IPO of the year, is set to debut on Nasdaq with an offering price of $29 per share for 216 million shares, aiming to raise approximately $6.26 billion, which values the company at around $39 billion [7]. - The company has reported revenues of $20.6 billion and a net profit of $977 million for the past nine months, showing an increase from $18.7 billion in revenue and $911 million in net profit in the same period last year [7]. - Major investors in Medline's IPO include Blackstone, Carlyle Group, and Hellman & Friedman, with cornerstone investors committing up to $2.35 billion [8].

Group 1: Nasdaq's All-Day Trading Initiative - Nasdaq has submitted a proposal to the SEC to launch "all-day trading" services starting in 2026, aiming to meet the growing demand for continuous trading from investors [1][2] - The plan includes extending daily trading hours from 16 to 23 hours, operating five days a week, with a new schedule that includes a one-hour maintenance window [3] - This initiative reflects a trend towards globalization in trading, with other exchanges like the New York Stock Exchange and Chicago Board Options Exchange also announcing similar plans [2][4] Group 2: Medline's IPO - Medline's IPO, set to take place on December 17, is expected to be the largest in the U.S. for the year, with a pricing of $29 per share for 216 million shares, aiming to raise approximately $6.26 billion [4][5] - The company, which produces medical supplies, has seen significant growth, reporting revenues of $20.6 billion and a net profit of $977 million for the past nine months [5][6] - Medline's IPO is notable as it ranks among the few U.S. IPOs in the last decade to raise over $5 billion, joining the ranks of companies like Uber and Rivian [6]

Group 1: Nasdaq's All-Day Trading Initiative - Nasdaq has submitted a proposal to the SEC to launch "all-day trading" services starting in 2026, aiming to meet the growing demand for continuous trading from investors [1][2] - The plan includes extending daily trading hours from 16 hours to 23 hours, operating five days a week, with a new structure of daytime and nighttime trading sessions [3] - The initiative reflects a trend towards globalization in trading, with Nasdaq's president emphasizing the increasing global nature of the U.S. market [2][4] Group 2: Medline's IPO - Medline, the largest IPO of the year, is set to debut on Nasdaq on December 17, with an offering price of $29 per share for 216 million shares, aiming to raise approximately $6.26 billion [4][6] - The company, founded in 1966, specializes in medical supplies and has reported revenues of $20.6 billion and a net profit of $977 million for the past nine months [5] - Medline's existing shareholders include major private equity firms, and the IPO has attracted cornerstone investors with commitments totaling up to $2.35 billion [5][6]